NDC 62541-501

STENDRA

Avanafil

STENDRA is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Vivus Llc. The primary component is Avanafil.

Product ID62541-501_e10a546c-9a9c-1f78-e053-2a95a90a40d3
NDC62541-501
Product TypeHuman Prescription Drug
Proprietary NameSTENDRA
Generic NameAvanafil
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2022-01-01
Marketing CategoryNDA /
Application NumberNDA202276
Labeler NameVivus LLC
Substance NameAVANAFIL
Active Ingredient Strength50 mg/1
Pharm ClassesPhosphodiesterase 5 Inhibitor [EPC], Phosphodiesterase 5 Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 62541-501-30

30 TABLET in 1 BOTTLE (62541-501-30)
Marketing Start Date2022-01-01
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "STENDRA" or generic name "Avanafil"

NDCBrand NameGeneric Name
62541-501STENDRAAvanafil
62541-502STENDRAAvanafil
62541-503STENDRAAvanafil
72384-751Stendraavanafil
72384-752Stendraavanafil
72384-753Stendraavanafil
76299-320Stendraavanafil
76299-321Stendraavanafil
76299-322Stendraavanafil

Trademark Results [STENDRA]

Mark Image

Registration | Serial
Company
Trademark
Application Date
STENDRA
STENDRA
85565411 4526269 Live/Registered
METUCHEN PHARMACEUTICALS, LLC
2012-03-09

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.